Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo
Shuofeng Yuan(University of Hong Kong - Shenzhen Hospital), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Chris Chung‐Sing Chan(University of Hong Kong), Kah‐Meng Tee(Chinese University of Hong Kong), Zheng Zhu(University of Hong Kong), Jorge de la Peña(Universidad Católica de Murcia), Winger W. N. Mak(University of Hong Kong), Horacio Pérez‐Sánchez(Universidad Católica de Murcia), Jasper Fuk‐Woo Chan(Hong Kong Science and Technology Parks Corporation), Jinxia Zhang(Peking University), Cyril Chik‐Yan Yip(Queen Mary Hospital), Jian‐Piao Cai(University of Hong Kong), José P. Cerón‐Carrasco(Universidad Católica de Murcia), Zijiao Zou(University of Hong Kong), Kwok‐Hung Chan(University of Hong Kong), Helena den-Haan(Universidad Católica de Murcia), Kenn Ka‐Heng Chik(University of Hong Kong), Vincent Kwok‐Man Poon(Queen Mary Hospital)
Cited by 134
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k